Navigation Links
Sangamo BioSciences Announces First Quarter 2015 Conference Call and Webcast
Date:4/15/2015

RICHMOND, Calif., April 15, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the company will release its first quarter 2015 financial results after the market closes on Wednesday, April 22, 2015. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the company will review the quarter's financial results and discuss other business matters.

The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The conference ID number for the call is 20895051.  Participants may access the live webcast via a link on the Sangamo BioSciences website in the Investors section under Events and Presentations. For those unable to listen in at the designated time, a conference call replay will be available for one week following the conference call, from approximately 8:00 p.m. ET on April 22, 2015 to 11:59 p.m. ET on April 29, 2015. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 20895051.

About Sangamo
Sangamo BioSciences, Inc. is focused on Engineering Genetic CuresTM for monogenic and infectious diseases by deploying its novel DNA-binding protein technology platform in therapeutic gene regulation and genome editing. The Company has clinical stage programs to evaluate the safety and efficacy of novel ZFP Therapeutics® for the treatment of HIV/AIDS (SB-728-T), beta-thalassemia (SB-BCLmR-HSPC), and NGF-AAV for Alzheimer's disease (CERE-110). Sangamo's other therapeutic programs are focused on monogenic and rare diseases. The Company has formed a strategic collaboration with Shire International GmbH to develop therapeutics for hemophilia, Huntington's disease and other monogenic diseases, and with Biogen for hemoglobinopathies, such as sickle cell disease and beta-thalassemia. It has also established strategic partnerships with companies in non-therapeutic applications of its technology, including Dow AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the Company's website at www.sangamo.com.

ZFP Therapeutic® is a registered trademark of Sangamo BioSciences, Inc.

Logo - http://photos.prnewswire.com/prnh/20130102/SF35903LOGO

 


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Sangamo BioSciences CEO To Present State Of The Industry Address At Alliance For Regenerative Medicines Advanced Therapies Summit
2. Sangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific Conferences in October 2014
3. Sangamo BioSciences Announces Target Date For First IND For Sangamos In Vivo ZFN Genome-Editing Platform For Monogenic Diseases
4. Sangamo BioSciences Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple HIV-Infected Subjects Treated with SB-728-T
5. Five Sangamo Scientists Recognized By Thomson Reuters Among Most Highly Cited Researchers Worldwide Of 2014
6. Sangamo BioSciences to Focus on Advancing ZFP Therapeutic Pipeline at J.P. Morgan Healthcare Conference
7. Sangamo BioSciences Presents Data From Non-Human Primates Providing Proof Of Concept For Disruptive And Broadly Leverageable Platform For Protein Replacement Therapies
8. Sangamo BioSciences Presents Clinical Data From Key SB-728-T HIV Studies: Proof Of Concept For Ongoing Sustained Functional Control Of HIV Viral Load; Cytoxan Preconditioning Successfully Enhances Engraftment
9. Sangamo BioSciences Presents Clinical Data From SB-728-T HIV Study Demonstrating Long-Term Immune Reconstitution and Reduction in the HIV DNA Reservoir In Subjects with Long-Term Infection
10. Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia
11. Sangamo BioSciences Announces Pricing Of Public Offering Of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2018)... ... December 13, 2018 , ... It’s time to start thinking about New ... ideal weight and learn how to maintain a healthy lifestyle. Women’s Excellence is ... discussion with a wellness specialist to document goals, discuss expected results, and begin a ...
(Date:12/13/2018)... ... December 13, 2018 , ... Shady Grove Fertility (SGF), a nationally ... 50 states and 35 countries around the world, announced today it’s expanding its program ... practice. Dr. Li will see Mandarin and English-speaking patients in Rockville, MD ...
(Date:12/13/2018)... ... December 13, 2018 , ... Karius , Inc., a ... of an ongoing clinical study of adult patients undergoing allogeneic hematopoietic stem cell ... test that detects pathogen cell-free DNA in plasma, is an effective infectious disease ...
Breaking Medicine Technology:
(Date:12/14/2018)... MESA, Calif. (PRWEB) , ... December 14, 2018 , ... ... the Art of Dentistry, are helping patients in La Mesa, CA interested in cosmetic ... point for individuals whose teeth and gums are not aesthetically appealing because of decay, ...
(Date:12/13/2018)... , ... December 13, 2018 , ... Ross A. Clevens, ... RealSelf Hall of Fame, an honor recognizing the highest-rated and most active doctors on ... with medical aesthetic providers. Dr. Clevens has been named a “Distinguished Inductee,” a distinction ...
(Date:12/13/2018)... ... December 13, 2018 , ... HDAP now ... and approachable in their community. Delia Associates created a solid and scalable platform ... dealing with substance abuse in the greater Hunterdon County area. The nonprofit’s treatment ...
(Date:12/13/2018)... ... December 13, 2018 , ... Allegheny ... and Westfield Memorial Hospital, all part of Allegheny Health Network (AHN), have been ... Executives (CHIME). , Most Wired® is the industry-leading survey on IT adoption and ...
(Date:12/10/2018)... ... ... In the aftermath of 1960s feminist movement, multiple generations of men have ... Too movement. To redress the balance, author Steve Clarke wrote “The Man Book,” a ... they were always meant to be by highlighting the qualities and behaviors of a ...
Breaking Medicine News(10 mins):